How many studies have been conducted on Myleran?

BiohacksAI has indexed 276 PubMed studies on Myleran. 5% of studies involve human subjects.

What are the main research areas for Myleran?

The primary research domains for Myleran are 🔬 Oncology, ✨ Skin & Hair, 🫁 Respiratory. This is based on analysis of 276 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Myleran

An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.

276+ PubMed studies analyzed · Evidence Score: 40.1

Research Domains

Myleran has been studied across 11 research domains including 🔬 Oncology, ✨ Skin & Hair, 🫁 Respiratory, 🛡️ Immunity, 😴 Sleep. The primary research focus is 🔬 Oncology with 9% of studies addressing this area.

Loading evidence profile...

This evidence profile for Myleran is generated deterministically from 276 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.